Gabapentin as part of multimodal analgesia in a newborn with epidermolysis bullosa.
Allegaert
Karel
K
Naulaers
Gunnar
G
D000588:Amines / Q000627:therapeutic use*; D000700:Analgesics / Q000627:therapeutic use*; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004820:Epidermolysis Bullosa / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D000077206:Gabapentin; D006801:Humans; D007231:Infant, Newborn; D010147:Pain Measurement / Q000187:drug effects; D012867:Skin / Q000473:pathology; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
D000588:Amines; D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000701:Analgesics, Opioid; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin